Minnesota Gov. Jesse Ventura has signed a bill that will allow hospitals, doctors and healthcare professionals across the state to share patient safety information.
Minnesota Gov. Jesse Ventura has signed a bill that will allow hospitals, doctors and healthcare professionals across the state to share patient safety information.
The law, which takes effect August 1, 2001, changes the Minnesota Peer Review Statute, which previously focused on learning from medical accidents, but inhibited the exchange of information from one hospital to the next to avoid litigation.
The new law allows hospitals, doctors and medical staff to anonymously report medical errors in a Web-based registry that can be aggregated and accessed by other healthcare professionals and the public to prevent the same errors from occurring at other sites. This information will be available to hospitals throughout the state. Individual patient and caregiver information is not specified; only the data needed to learn from the event are provided.
"This law will improve patient safety," said Bruce Rueben, president of the Minnesota Hospital and Healthcare Partnership. "Minnesota hospitals fought hard to create this Web-based registry. By capturing and sharing information on medical accidents regardless of whether or not a patient is harmed, hospitals can provide safer care and prevent mistakes before they happen."
The new law does not diminish the responsibility of providers to report medical accidents in cases in which a patient is harmed. But Scott Anderson, vice president of information services for the MHHP, said the new program will enable healthcare providers to learn from others' mistakes.
"What makes this system truly unique is that it is voluntary," said Anderson. "Hospitals understand the importance of learning from each other. This system will help facilitate that process because it is designed to capture both adverse events and near misses." PR
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.